Table 3.
Outcomes | Groups | Before treatment | After treatment | P |
---|---|---|---|---|
WBC (×109/L) | Intervention | 5.47 (4.06–7.20) |
5.67 (4.67–7.10) |
.193 |
Control | 5.91 (4.57–8.54) |
5.95 (4.82–9.25) |
.853 | |
LYM (×109/L) | Intervention | 0.96 (0.67–1.60) |
1.63 (1.20–1.98) |
.000* |
Control | 1.03 (0.66–1.51) |
1.36 (0.98–1.75) |
.458 | |
LYM% | Intervention | 19.05 (10.53–29.93) |
27.3 (19.8–38.7) |
.000* |
Control | 17.3 (11.23–25.60) |
23.00 (12.48–33.98) |
.353 | |
CRP (mg/L) | Intervention | 18.6 (7.37–47.03) |
3.49 (0.93–10.05) | .000* |
Control | 18.5 (6.43–78.15) |
6.95 (2.45–41.37) |
.095 |
P < .05.